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Abstract
Background: High-sensitivity C-reactive protein (hs-CRP) is an easily measured inflammatory biomarker. This study
compared the association of percent body fat mass (%FM), body mass index (BMI), waist circumference (WC), and
waist-to-hip ratio (WHR) with hs-CRP in a Taiwanese population.
Methods: A total of 1669 subjects aged 40-88 years were recruited in 2004 in a metropolitan city in Taiwan. The
relationships between obesity indicators and a high level of hs-CRP were examined using multivariate logistic
regression analysis. The upper quartile of the hs-CRP distributions was defined as the high category group. The
areas under the curve (AUCs) of the receiver operating characteristic curves were calculated for all obesity
indicators to compare their relative ability to correctly classify subjects with a high level of hs-CRP.
Results: After multivariate adjustment, the odds ratio for %FM was the only significant indicator that was
associated with a high level of hs-CRP in men (1.55, 95% CI: 1.07-2.25). All indicators were associated with a high
level of hs-CRP in women. In men, the AUCs for %FM were significantly higher than those for BMI, WHR, and WC,
when demographic and lifestyle behaviors were considered (p < 0.001 for all comparisons), but they were not
significantly different in females.
Conclusions: Our study demonstrates that %FM is the only obesity indicator that is strongly associated with a
high level of hs-CRP after adjusting for sociodemographic factors, lifestyle behaviors and components of metabolic
syndrome in both genders in a Taiwanese population aged forty years and over. In men, %FM had the greatest
ability to classify subjects with a high level of hs-CRP when only demographic and lifestyle behaviors were
considered. Our study finding has important implications for the screening of obesity in community settings.
Background
Obesity is a major public health problem in the world,
affecting people in both developed and developing coun-
tries [1-4]. According to reports, there are about 250
million adults suffering from obesity [5,6]. A previous
survey has shown that the age-adjusted prevalence of
obesity is rapidly increasing in Taiwan, from 10.5% to
15.9% for men from 1993-1996 to 2000-2001 [7]. Of
most importance, obesity is associated with numerous
chronic health conditions or diseases, such as diabetes,
hypertension, and cardiovascular disease [8,9].
High-sensitivity C-reactive protein (hs-CRP), the main
acute phase protein in humans,i sas e n s i t i v em a r k e rf o r
systemic inflammation. Previous cross-sectional studies
have shown that elevated hs-CRP levels correlate signifi-
cantly with features of metabolic abnormality, including
adiposity, hyperinsulinemia, insulin resistance,
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cholesterol (HDL-C) [10-13]. Although the physiological
mechanisms linking elevated hs-CRP to these disorders
are not known, it is possible that the association is partly
mediated by adipose tissue, a main source of inflammatory
cytokines. Most epidemiologic studies identifying strong
associations between hs-CRP and obesity indicators predo-
minantly use anthropometric indexes [10-13]. Only a few
studies have used measures of body fat [14-16].
Body mass index (BMI) is an indicator of heaviness
rather than fatness, and cannot distinguish body fat from
fat-free mass. Waist-to-hip ratio (WHR) is a measure of
regional fat distribution, whereas waist circumference
(WC) is a measure of central obesity. Bio-electrical
impedance analysis (BIA) produces a close estimate of
fat-free mass throughout a wide range of body compo-
sition [17]. BIA is a non-invasive measurement of body
composition and is especially useful in large epidemio-
logic studies. It also possesses many advantages over
other methods, in that it is inexpensive, simple, fast,
safe, portable, easy-to-perform, and requires minimal
operator training [18,19]. The current study was
designed to explore the values of obesity indicators of
percent body fat mass (%FM), as determined by BIA
for the total body, compared to BMI, WC, and WHR,
in terms of their independent relation to hs-CRP
under two conditions: one considering metabolic syn-
drome (MetS)’s components, except obesity, and the
other not considering these MetS components.
Methods
Participants
This was a community-based cross-sectional study based
on data from the Taichung Community Health Study.
The detailed methodology has been described elsewhere
[20-25]. A total of 2,359 residents of Taichung City,
Taiwan, aged 40 and over, participated in the study in
October 2004. Hs-CRP levels were measured only for
the first 1669 consecutive subjects. This study was
approved by the Human Research Committee of China
Medical University Hospital. Written informed consent
was obtained from each participant.
Anthropometric measurements and laboratory
examinations
Anthropometric measurements and blood samples were
obtained from the complete physical examination.
Weight and height were measured on an auto-anthrop-
ometer (super-view, HW-666), with the subjects shoeless
and wearing light clothing. BMI was derived from the
formula, weight (kg) ÷ (height)
2 (m
2). With the partici-
pant standing, WC was measured midway between the
superior iliac crest and the costal margin, and hip cir-
cumference at its maximum protrusion point of the
buttocks around the pelvis, and then the WHR was cal-
culated as a measure of regional fat distribution. %FM
was assessed by a body composition analyzer (Tanita
BC-418, Arlington Heights, Illinois, USA). The measure-
ments were performed with the subjects stepping onto
the measuring platform without shoes and after wiping
the soles of their feet. The amount of body fat was
expressed as a percentage of total weight. Previous stu-
dies have confirmed the validity of BIA in estimating
body composition compared to dual energy X-ray
absorptiometry (DEXA) [19,26]. The means values for
BIA and DEXA were very close [26]. BIA was a good
predictor of DEXA-derived fat-free mass (r = 0.85-0.88)
and was superior to BMI in measuring body fat [19].
The principle of BIA is that fat tissue exhibits greater
resistance to the flow of electrical current than fat-free
tissue because of differences in water content.
Blood pressure was measured by an electronic device
(COLIN, VP-1000, Japan) three times after the subjects
had rested for 20 minutes. The lowest systolic and dia-
stolic blood pressure was recorded. Blood was drawn
from an antecubital vein in the morning after a 12-hour
overnight fasting and was sent for analysis within four
hours of blood collection. Hs-CRP levels were measured
by nephelometry, a latex particle-enhanced immunoas-
say (TBA-200FR, Tokyo, Japan). The interassay and
intra-assay CVs were <2.0% and <1.9%, respectively. The
lower detection limit of the assay was 0.1 mg/L.
Biochemical markers such as fasting plasma glucose,
HDL-C, and triglyceride were analyzed by a biochemical
autoanalyzer (Beckman Coulter Synchron system, Lx-20,
Fullerton, CA, USA) at the Clinical Laboratory Depart-
ment of China Medical University Hospital. Fasting
plasma glucose was measured in blood obtained by use
of NAF TUBE. NAF TUBE contains 5 mg sodium fluor-
ide to inhibit glucose metabolism and 4 mg potassium
oxalate to chelate calcium and prevent coagulation. The
interassay and intra-assay CVs for fasting plasma glu-
cose were 4% and 4%, respectively. We measured cho-
lesterol and triglyceride in serum mode. A SST tube was
used. The SST™ tube refers to the Serum Separator
Tube containing clot activator and serum separator gel.
The silica particles that coat the walls of the BD Vacu-
tainer® SST™ tube are the clot activator. Initial activation
occurs when blood enters the tube and contacts the par-
ticles on the tube wall. Triglyceride levels were deter-
mined using an enzymatic colorimetric method. The
interassay and intra-assay CVs for triglyceride were 6.8%
and 5%, respectively. The HDL-C level was measured by
a direct HDL-C method and the interassay and intra-
assay CVs were 4.5% and 4.5%, respectively. The low-
density lipoprotein cholesterol (LDL-C) level was also
measured using a direct LDL-C method, and interassay
and intra-assay CVs were 4.5% and 3%, respectively. The
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Page 2 of 8serum insulin level was measured by a commercial
enzyme-linked immunosorbent assay kit (Diagnostic Pro-
ducts, Los Angeles, CA). The interassay CV for insulin
was 8.7% and the intra-assay CV was 3.4%. Insulin sensi-
tivity was estimated with a Homeostasis Model Assess-
ment (HOMA-IR) equation. The HOMA-IR equals
fasting serum insulin (μU/ml) times fasting plasma glu-
cose (mmol/l) divided by 22.5 [27]. The cut-offs defining
abnormality of triglycerides, HDL-C, blood pressure, and
fasting glucose were in accordance with the AHA/NHLBI
statement that was used to define the four components of
MetS [28]: elevated triglycerides (≥150 mg/dL), reduced
HDL-C (< 40 mg/dL for men, <50 mg/dL for women),
elevated blood pressure (BP ≥130/≥85 mmHg), and ele-
vated fasting glucose (≥100 mg/dL).
Data regarding smoking, alcohol drinking, physical
activity, betel nut chewing and family history of cardio-
vascular-related diseases were collected by questionnaire
when the participants underwent a complete physical
examination. Subjects who self-reported any of these
characteristics (smoking, alcohol drinking, betel nut
chewing and family history of cardiovascular-related dis-
eases) were placed into groups based on the specific
characteristic. Those in the non-smoking group had
never smoked or had smoked less than 100 cigarettes
during their lifetime, whereas those in smoking group
smoked currently or had smoked more than or equal to
100 cigarettes during their lifetime. Individuals who self-
reported alcohol drinking, betel nut chewing or exercise
were classified into the group with this specific charac-
teristic. Those whose parents or siblings had a specific
cardiovascular-related disease were classified as having a
family history of the disease.
Statistical analysis
Continuous variables were reported as means, whereas
categorical variables were reported as numbers (percen-
tage). The cutoff points for WC [28] were 90 (cm) for
men and 80 (cm) for women, and for WHR [29] were
0.9 in men and 0.85 in women. The value of the cutoff
point of BMI for defining overweight was 24 [30]. We
defined the subjects in the upper quartile of the %FM
and hs-CRP distributions as the high category group. To
examine the relationship between obesity indicators and
hs-CRP, crude odds ratios (ORs) were first used; then,
multivariate logistic regression analysis was used to
investigate the independent effect on the high level of
hs-CRP, adjusting for age, smoking, alcohol drinking,
and betel nut chewing. Finally, variables for abnormality
of the MetS components other than obesity were
entered into models. ORs and their 95% confidence
intervals were calculated. The areas under curve (AUCs)
for each receiver operating characteristics curve were
calculated to compare the relative ability of obesity indi-
cators to correctly classify subjects with a high level of
hs-CRP, and the nonparametric method was used to test
whether the AUCs of these four obesity indicators were
different [31]. All analyses were conducted using SAS
version 9.1 (SAS Institute Inc, Cary, NC). A two-sided
significant level of p < 0.05 was reported.
Results
A total of 1669 subjects (807 men and 862 women)
were analyzed in the final model. The sociodemographic
and anthropometric characteristics and biomarkers of
the obese participants, as defined by %FM, BMI, WHR,
and WC, and stratified by gender, are summarized in
Tables 1 and 2. Obese participants, both men and
women, identified by these four obesity indicators had
similar characteristics.
Table 3 shows the ORs of the high level of hs-CRP for
each obesity indicator for men and women. Without
considering any covariates, all ORs were significant,
except BMI, and ORs were largest for %FM for both
men and women (OR: 1.94, 95% CI: 1.37-2.73 in men;
OR: 3.59, 95% CI: 2.59-4.98 in women). After adjusting
for age, smoking status, alcohol drinking, and betel nut
chewing, the effect of %FM still remained significant
(OR: 1.89, 95% CI: 1.33-2.68 in men; OR: 3.34, 95% CI:
2.39-4.68 in women). After further adjusting for hyper-
glycemia, hypertriglyceridemia, hypertension, and low
HDL-C, the OR for %FM became attenuated, but
remained significant (1.55, 95% CI: 1.07-2.25 in men;
OR: 2.89, 95% CI: 2.03-4.11 in women). In women, the
crude ORs for the four obesity indicators were all statis-
tically significant. These ORs remained significant after
considering age, smoking, alcohol drinking, betel nut
chewing, and the four components of MetS. The high
categories of BMI, WHR, and WC were associated with
a 2.11-fold (95% CI: 1.51-2.95), 2.07-fold (1.45-2.97) and
2.37-fold (1.67-3.35) increased risk of having a high level
of hs-CRP, respectively.
The AUCs and 95% CIs of four obesity indicators stra-
tified by gender are shown in Table 4. In men, the
AUCs for BMI, WC, and WHR were similar and were
all significantly lower than that for %FM (c
2 for overall
test = 14.77, p = 0.002, the p values for pair-wise com-
parisons were all <0.001, Figure 1). On the other hand,
in women, the AUCs for %FM, BMI, and WC were
similar and were slightly higher than that for WHR, but
there were no significant differences between the AUCs
for the different obesity indicators (c
2 =5 . 5 5 ,p=
0.1355, Figure 2). After further adjusting for the four
components of MetS, the differences between the AUCs
for the four obesity indicators were no longer statisti-
cally significant in men.
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Page 3 of 8Table 1 Prevalence of cardiovascular risk factors in obese individuals as defined by each obesity indicator, and
stratified by gender, n (%)
Male Female
Obesity defined by Obesity defined by
Variables %FM
(≧29.6)
BMI
(≧24)
WHR
(≧0.9)
WC
(≧90 cm)
%FM
(≧40.1)
BMI
(≧24)
WHR
(≧0.85)
WC
(≧80 cm)
Obesity 203 (25.15) 478 (59.23) 340 (42.13) 240 (29.74) 222 (25.75) 366 (42.46) 189 (21.93) 250 (29.00)
Smoking
a 65 (32.02) 139 (29.08) 118 (34.81) 80 (33.33) 8 (3.62) 10 (2.74) 6 (3.17) 7 (2.80)
Drinking
b 77 (37.93) 189 (39.54) 128 (37.76) 98 (40.83) 16 (7.24) 27 (7.40) 15 (7.94) 17 (6.80)
Betel nut chewing
b 14 (6.90) 37 (7.76) 27 (8.01) 17 (7.08) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
Exercise
b 135 (66.50) 320 (66.95) 221 (65.19) 164 (68.33) 135 (60.81) 236 (64.48) 121 (64.02) 155 (62.00)
Family history of diabetes
c 48 (23.65) 116 (24.27) 72 (21.18) 53 (22.08) 52 (23.42) 98 (26.78) 46 (24.34) 58 (23.20)
Hyperglycemia 111 (54.68) 231 (48.33) 168 (49.41) 131 (54.58) 97 (43.69) 153 (41.80) 86 (45.50) 114 (45.60)
Hypertriglyceridemia 102 (50.25) 183 (38.28) 143 (42.06) 104 (43.33) 64 (28.83) 101 (27.60) 62 (32.80) 74 (29.60)
Hypertension 174 (85.71) 354 (74.06) 264 (77.65) 201 (83.75) 163 (73.42) 244 (66.67) 129 (68.25) 185 (74.00)
Low HDL cholesterol 136 (67.00) 301 (62.97) 212 (62.35) 151 (62.92) 157 (70.72) 248 (67.76) 131 (69.31) 171 (68.40)
High level of hs-CRP 74 (36.45) 137 (28.66) 104 (30.59) 76 (31.67) 105 (47.30) 140 (38.25) 83 (43.92) 109 (43.60)
%FM: percent body fat mass, BMI: body mass index, WHR: waist-to-hip ratio, WC: waist circumference, high-density lipoprotein (HDL), high-sensitivity C-reactive
protein (hs-CRP).
a: Those in the non-smoking group had never smoked or had smoked less than 100 cigarettes during their lifetime, whereas those in the smoking group smoked
currently or had smoked more than or equal to 100 cigarettes during their lifetime.
b: Individuals who self-reported the characteristics of alcohol drinking, betel chewing or exercise were classified into the group with this specific characteristic.
c: Those whose parents or siblings had diabetes were classified as having a family history of diabetes.
Table 2 Distributions of sociodemographic and biochemical characteristics in obese individuals defined by each
obesity indicator, and stratified by gender
Obesity defined by*
%FM BMI WHR WC
Variables Mean SD Mean SD Mean SD Mean SD
Male
Age (years) 59.6 12.7 57.4 12.0 60.1 12.4 59.5 12.4
Fasting blood glucose (mmol/L) 6.1 1.7 5.9 1.6 6.1 1.9 6.1 1.8
Fasting insulin (pmol/L) 96.6 61.0 75.4 52.1 76.1 51.2 91.9 58.1
HOMA-IR 3.7 2.7 2.8 2.3 2.9 2.4 3.6 2.7
Triglyceride (mmol/L) 1.8 1.0 1.7 1.4 1.8 1.40 1.8 1.5
HDL-cholesterol (mmol/L) 1.0 0.2 1.0 0.2 1.0 0.2 1.0 0.3
LDL-cholesterol (mmol/L) 3.5 0.9 3.3 0.8 3.4 0.9 3.4 0.9
Diastolic blood pressure (mmHg) 86.1 8.8 83.5 10.1 83.9 9.8 84.9 9.1
Systolic blood pressure (mmHg) 144.9 17.8 139.2 19.1 141.2 19.2 142.9 18.1
Hs-CRP (mg/l)
# 0.18 1.05 0.16 1.03 0.17 1.04 0.17 1.05
Female
Age (years) 58.8 10.2 57.0 9.7 58.4 11.5 58.7 10.6
Fasting blood glucose (mmol/L) 6.1 1.9 5.9 1.8 6.0 1.8 6.1 2.0
Fasting insulin (pmol/L) 82.4 54.4 74.5 55.6 83.6 65.7 79.2 60.4
HOMA-IR 3.2 2.6 2.9 2.8 3.3 3.4 3.2 3.2
Triglyceride (mmol/L) 1.5 0.9 1.4 0.8 1.5 1.0 1.5 0.9
HDL-cholesterol (mmol/L) 1.2 0.3 1.2 0.3 1.2 0.3 1.2 0.3
LDL-cholesterol (mmol/L) 3.5 0.8 3.5 0.8 3.4 0.8 3.4 0.8
Diastolic blood pressure (mmHg) 80.8 11.6 79.0 11.7 79.1 11.3 80.1 11.3
Systolic blood pressure (mmHg) 143.3 21.9 139.3 21.6 139.7 22.6 142.0 22.0
Hs-CRP (mg/l)
# 0.21 1.05 0.18 1.04 0.20 1.05 0.21 1.05
%FM: percent body fat mass, BMI: body mass index, WHR: waist-to-hip ratio, WC: waist circumference, homeostasis model assessment of insulin resistance
(HOMA-IR), high-density lipoprotein (HDL), low-density lipoprotein (LDL), high-sensitivity C-reactive protein (hs-CRP).
#: geometric mean was presented.
*The cutoff values for %FM: ≥29.6 in men and ≥40.1 in women; for BMI: ≥24; for WHR: ≥0.9 in men and ≥0.85 in women; for WC: ≥90 cm in men and ≥80 in women.
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In this community-based study, we demonstrated that
all obesity indicators, except WHR in men, were
strongly associated with a high CRP level in Taiwanese
men and women when sociodemographic factors and
lifestyle behaviors were considered. Only the association
for %FM remained significant in women after further
considering individual abnormalities in the four compo-
nents of MetS.
Hs-CRP is an easily measured inflammatory biomarker
and is released by the liver under the stimulation of
cytokines, including interleukin-6, interleukin-1, and
tumor necrosis factor-alpha. It has been shown hs-CRP
has associations with endothelial dysfunction and insulin
resistance syndrome [32]. Although a relationship has
been found between hs-CRP and DEXA-measured trunk
fat [33], our finding is the first to show that hs-CRP is
only associated with %FM in men and women compared
with BMI, WHR, and WC, indicating that %FM is the
obesity indicator that can capture the inflammatory phe-
nomena in both genders that are responsible for the
higher likelihood of diabetes and cardiovascular events.
In addition, %FM had a greater ability to classify sub-
jects with a high level of hs-CRP compared with BMI,
WHR, and WC in men, when demographic and lifestyle
behaviors were considered, but this ability diminished
when MetS components were considered. This finding
has important implications for obesity screening in com-
munity surveys. The BIA measurement may not be
more valuable than the other obesity indicators when
health surveys use blood samples, but is a measurement
worth using when the health survey for screening obe-
sity does not draw blood samples.
WHR has been the traditional anthropometric index
for assessing central adiposity; however, the use of WC
is gaining support [34-37] and popularity as an alterna-
tive, simpler option [38-40]. WHR was the only obesity
indicator that did not perform well in men in identifying
individuals with a high hs-CRP level after adjusting for
age, smoking, alcohol drinking, and betel nut chewing.
In Craig’s work, WHR did not perform well in identify-
ing risk factors for cardiovascular disease and undiag-
nosed diabetes [41]. In addition, the correlations with
individual risk factors were weaker than those of other
measures of body composition, especially in women
[41]. On the other hand, WHR explained the highest
percentage of the variability of CRP in men in Thorand’s
work [15], and WHR was significantly correlated
with CRP in both men and women [16]. The possible
Table 3 The odds ratios of a high level of hs-CRP for
obesity as defined by %FM, BMI, WHR, and WC
a
OR (95%)
Univariate model Men Women
BMI 1.36 (0.98, 1.88) 2.68 (1.97, 3.66)
WHR 1.47 (1.07, 2.01) 2.73 (1.94, 3.84)
WC 1.47 (1.05, 2.05) 3.04 (2.21, 4.18)
%FM 1.94 (1.37, 2.73) 3.59 (2.59, 4.98)
Multivariate model§
BMI 1.45 (1.04, 2.02) 2.56 (1.86, 3.50)
WHR 1.26 (0.90, 1.74) 2.50 (1.77, 3.54)
WC 1.42 (1.01, 1.99) 2.81 (2.02, 3.90)
%FM 1.89 (1.33, 2.68) 3.34 (2.39, 4.68)
Multivariate model&
BMI 1.25 (0.87, 1.77) 2.11 (1.51, 2.95)
WHR 1.06 (0.76, 1.50) 2.07 (1.45, 2.97)
WC 1.19 (0.83, 1.70) 2.37 (1.67, 3.35)
%FM 1.55 (1.07, 2.25) 2.89 (2.03, 4.11)
Multivariate model&f
BMI 1.12 (0.93, 1.33) 1.65 (1.39, 1.97)
WHR 1.09 (0.90, 1.31) 1.40 (1.19, 1.66)
WC 1.18 (0.98, 1.41) 1.76 (1.48,2.12)
%FM 1.50 (1.25, 1.80) 1.72 (1.42, 2.10)
%FM: percent body fat mass; BMI: body mass index; WHR: waist-to-hip ratio;
WC: waist circumference.
a: The cutoff values for %FM: ≥29.6 in men and ≥40.1 in women; for BMI: ≥24;
for WHR: ≥0.9 in men and ≥0.85 in women; for WC: ≥90 cm in men and ≥80
in women.
§: Logistic regression adjusted for age, smoking, alcohol drinking and betel
nut chewing.
&: Logistic regression adjusted for age, smoking, alcohol drinking, betel nut
chewing, hyperglycemia, hypertriglyceridemia, hypertension and low HDL
cholesterol.
f: per 1-SD increment.
Table 4 Comparisons of AUCs for percent body fat mass,
body mass index, waist-to-hip ratio, and waist
circumference, stratified by gender
Male Female
AUC 95% CI x
2 AUC 95% CI x
2
ROC curve§ 14.77**
a 5.55
%FM 0.67 0.62, 0.71 0.69 0.65, 0.73
BMI 0.62 0.57, 0.66 0.69 0.65, 0.73
WHR 0.61 0.57, 0.66 0.65 0.61, 0.70
WC 0.62 0.58, 0.67 0.69 0.65, 0.73
ROC curve& 7.74 6.81
%FM 0.68 0.63, 0.72 0.71 0.67, 0.75
BMI 0.65 0.60, 0.69 0.71 0.67, 0.75
WHR 0.64 0.60, 0.69 0.69 0.65, 0.73
WC 0.65 0.60, 0.69 0.71 0.67, 0.75
%FM: percent body fat mass; BMI: body mass index; WHR: waist-to-hip ratio;
WC: waist circumference, AUC: area under curve.
**: p < 0.01;
a: AUC of ROC curve for %FM was significant larger than those for BMI, WHR,
and WC.
§: Logistic regression adjusted for age, smoking, alcohol drinking and betel
nut chewing.
&: Logistic regression adjusted for age, smoking, alcohol drinking, betel nut
chewing, hyperglycemia, hypertriglyceridemia, hypertension and low HDL
cholesterol.
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Page 5 of 8Figure 1 The receiver operating characteristics curves of BMI, WHR, WC and %FM for males.
Figure 2 The receiver operating characteristics curves of BMI, WHR, WC and %FM for females.
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Page 6 of 8explanation for the differences in the findings among
these studies was that these studies were conducted
with different ethnic groups, or the populations in these
studies had different levels or types of obesity.
The limitations of this study must be considered. The
principal limitation relevant to the interpretation of our
results is the use of cross-sectional data; thus, causal
pathways underlying the observed relationships cannot
be inferred. Second, these analyses were restricted to the
first 1669 subjects entering the current study, indicating
that potential selection bias might exist. To assess this
possibility, we examined the demographic characteristics
of the individuals with and without hs-CRP measure-
ment by comparing age, sex, and administrative
unit, and similar distributions were found. The non-
differential distributions in age, sex, and administrative
unit indicate this kind of selection error might be ran-
dom, thus, the biased results in the effect may be toward
the null, a lesser threat to validity.
Conclusion
In summary, this study demonstrates that %FM is
strongly associated with a high level of hs-CRP in both
genders in a Taiwanese population aged forty years and
over. The novelty of the study is that %FM is the only
significant indicator related to hs-CRP among various
anthrometric indexes in men when demographic and
lifestyle behaviors, and the individual components of
MetS are considered. This finding highlights the impor-
tance of %FM in screening obese individuals who have a
higher likelihood of chronic inflammation, especially
when no blood sample is drawn. BIA measurement
offers a convenient and practical approach to body com-
position assessment and may be useful and valuable in
community settings. Our study finding has important
implications for the screening of obesity.
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